Thyroid Cancer Trial, Recruiting (NCT06539702)

Thyroid Cancer Trial, Recruiting NCT06539702 Sponsor: Saglik Bilimleri Universitesi Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06539702 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old
You have received a "Bethesda III" result from a needle biopsy of your thyroid (a type of unclear or uncertain biopsy result) and have decided to have thyroid surgery

Who may not be able to join:

You are outside the age range of 18 to 75 years old (confirm with trial site, as this appears to overlap with the inclusion criteria)
A needle biopsy of your thyroid showed an uncertain result in one area, but cancer was also found in a different area of your thyroid before surgery
After thyroid surgery, cancer was found in a part of your thyroid other than the area that had the uncertain biopsy result
Your blood test results from before surgery were not available
You do not agree to have your tissue tested for a specific gene change called BRAF

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ugur Kesici, Assoc.Prof., Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phone: 00905445474710

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06539702

Sponsor: Saglik Bilimleri Universitesi

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 00905445474710

More information: https://clinicaltrials.gov/study/NCT06539702

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old
You have received a "Bethesda III" result from a needle biopsy of your thyroid (a type of unclear or uncertain biopsy result) and have decided to have thyroid surgery

Who may not be able to join:

You are outside the age range of 18 to 75 years old (confirm with trial site, as this appears to overlap with the inclusion criteria)
A needle biopsy of your thyroid showed an uncertain result in one area, but cancer was also found in a different area of your thyroid before surgery
After thyroid surgery, cancer was found in a part of your thyroid other than the area that had the uncertain biopsy result
Your blood test results from before surgery were not available
You do not agree to have your tissue tested for a specific gene change called BRAF

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Saglik Bilimleri Universitesi

Registry

ClinicalTrials.gov

Start date

20 July 2024

Est. completion

6 August 2024

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Mean Platelet Volume (MPV) (fL); Neutrophil/lenfosit Ratio (NLR)(103/µL); Platelet/Lenfosit Ratio (PLR)(103/µL); Lenfosit/Monosit Ratio (LMR)(103/µL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov